This Solicitation opportunity from Department Of Defense was posted on July 13, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
FENTANYL CITRATE IN
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Fentanyl Citrate Injection, USP, in 50 mcg/mL strength, supplied in glass ampuls, is being procured under solicitation SPE2DP-26-T-4090 by the Department of Defense through DLA Medical Supply Chain Pharm FSA. Each unit of issue is a package containing ten ampuls, with a total contract quantity of twenty packages, requiring delivery within five days of order issuance to the destination in Suffolk, VA. The product is a Schedule II controlled substance intended solely for intravenous or intramuscular administration, must be sterile and nonpyrogenic, and stored at 20°–25°C (68°–77°F) while protected from light. A minimum of thirty-one months of shelf life must remain at the time of receipt, with a total shelf life of thirty-six months that is nonextendable. All packaging, labeling, and marking must strictly conform to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical items, and must include proper barcoding and identification per current DLA logistics standards. The item is manufactured by Pfizer Inc under NDC 00409-9093-11 and is regulated by the FDA; contractors must ensure compliance with all technical and quality requirements from the DLA Master List of Technical and Quality Requirements, including RP001 for packaging and RQ011 for removal of government identification from non-accepted supplies. Shipping must occur via the fastest traceable means excluding parcel post, using commercial containers compliant with ASTM D3951 for non-hazardous materials or IP025 if classified as hazardous under FED-STD-313, with palletization adhering to RP001. Delivery is FOB destination, with inspection and acceptance occurring at the delivery point, and invoicing must be processed electronically through WAWF. Compliance with cybersecurity requirements is mandated under FAR 252.204-7012 to safeguard covered defense information, and adherence to multiple FAR clauses including those on trafficking in persons, employment eligibility verification, sustainable products, hazardous material identification, and whistleblower protections is required. Offerors must possess a valid UEI and CAGE code, declare small business status if applicable, and fully comply with all DLA and DoD regulatory frameworks governing medical procurement, including deviation exceptions granted under specific contract clauses for current policy alignment.
General Info
Agency
NAICS
Place of Performance
DOORWAY 71, SUFFOLK, VA, 23435-5000, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
FENTANYL CITRATE INJECTION, USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
. RX ONLY, FOR INTRAVENOUS OR INTRAMUSCULAR ADMINISTRATION.. STERILE
AND NONPYROGENIC..
DEA SCHEDULE II CONTROLLED SUBSTANCE.. ROUTE: INJECTION DOSE FORM:
AMPUL (ML) STRENGTH: 50 MCG/ML (0.05 MG/ML) 50 MCG = 0.05 MG = 1 ML.
FOR INTRAVENOUS OR INTRAMUSCULAR USE ONLY. UNIT OF ISSUE IS A PACKAGE
CONTAINING 10 EACH (GLASS AMPULS)
. TOTAL SHELF LIFE IS 36 MONTHS.. THERE SHALL BE A MINIMUM OF 31 MONTHS
OF REMAINING SHELF LIFE AT THE TIME OF RECEIPT BY THE FIRST GOVERNMENT
ACTIVITY.. STORE AT 20°-25°C (68°-77°F). [SEE USP CONTROLLED ROOM
TEMPERATURE]. PROTECT FROM LIGHT.. LABELING AND MARKING MUST IN
ACCORDANCE WITH MEDICAL MARKING STANDARD NO.1C...
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 PG = 10 EA RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
SPE2DP-26-T-4090
SECTION B
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
PFIZER INC 86491 P/N NDC00409-9093-11
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017458237 0001 PG 20.000
NSN/MATERIAL:6505010104170
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
N23410
PCU JOHN F KENNEDY CVN-79
6701 COLLEGE DRIVE
SPE2DP-26-T-4090
SECTION B
PR: 7017458237 PRLI: 0001 CONT’D
DOORWAY 71
SUFFOLK VA 23435-5000
US
RDD 999/NMCS SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
N23410
PCU JOHN F KENNEDY CVN-79
6701 COLLEGE DRIVE
DOORWAY 71
SUFFOLK VA 23435-5000
US
M/F: (TCN) N234106191ZH02
RDD: 999
PROJ: ZD8 TP 1
SUPP ADD: N62645 SIG: B
FOR GOVERNMENT USE ONLY: (IPD) 03
DIC: A0A DIST: M9L ADV: 2A FC: 68
Need Ship Date:00/00/0000 Original Required Delivery Date:07/15/2026
SPE2DP-26-T-4090 NSN/Part Number: 6505-01-010-4170 Quantity: 20 PG Purchase Request: 7017458237QTY: 20 Delivery: 5 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS